Publication

Genetic manipulation of drug sensitivity in haematopoietic cells.

Southgate, Thomas D
; 
Fairbairn, Leslie J
Citations
Altmetric:
Abstract
The haematopoietic system can be manipulated genetically to increase either its resistance to drugs or its sensitivity to certain agents. Gene transfer and expression of specific drug-resistance factors might protect haematopoietic function during antitumour chemotherapy, or allow enrichment of gene-modified cells in vivo. By contrast, gene transfer of a prodrug activator, to confer sensitivity to otherwise nontoxic prodrugs, might allow deletion of engrafted cells in the event of an adverse effect such as graft-versus-host disease or the induction of a neoplasm. In addition, expression of a prodrug activator in tumour-infiltrating haematopoietic cells could provide a means of specifically activating a cytotoxic agent within a tumour mass.
Authors
Southgate, Thomas D
Fairbairn, Leslie J
Affiliation
Cancer Research UK Gene Therapy Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX, UK. tsouthgate@picr.man.ac.uk
Description
Date
2004-08-06
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Haematopoietic Stem Cell Transplantation
Haematopoietic Stem Cells
Tumour Suppressor Proteins
Type
Article
Citation
Genetic manipulation of drug sensitivity in haematopoietic cells. 2004, 6 (18):1-24 Expert Rev Mol Med
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/78371
Embedded videos